Home314130 • KOSDAQ
add
Genome&Company
Previous close
â‚©2,930.00
Day range
â‚©2,800.00 - â‚©3,000.00
Year range
â‚©2,705.00 - â‚©7,335.00
Market cap
85.91B KRW
Avg Volume
327.95K
P/E ratio
-
Dividend yield
-
Primary exchange
KOSDAQ
Market news
Financials
Income Statement
Revenue
Net income
(KRW) | Sep 2024info | Y/Y change |
---|---|---|
Revenue | 4.62B | 3.70% |
Operating expense | 9.69B | -20.59% |
Net income | -6.79B | 24.59% |
Net profit margin | -146.92 | 27.27% |
Earnings per share | — | — |
EBITDA | -5.94B | 29.49% |
Effective tax rate | 7.32% | — |
Balance Sheet
Total assets
Total liabilities
(KRW) | Sep 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 78.21B | -21.75% |
Total assets | 151.77B | -15.93% |
Total liabilities | 49.68B | 0.27% |
Total equity | 102.10B | — |
Shares outstanding | 24.43M | — |
Price to book | 1.42 | — |
Return on assets | -12.66% | — |
Return on capital | -14.38% | — |
Cash Flow
Net change in cash
(KRW) | Sep 2024info | Y/Y change |
---|---|---|
Net income | -6.79B | 24.59% |
Cash from operations | -6.71B | -1.53% |
Cash from investing | -9.39B | -133.64% |
Cash from financing | 4.20B | -50.50% |
Net change in cash | -14.90B | -2,215.63% |
Free cash flow | -3.33B | 77.69% |
About
Founded
2015
Website
Employees
90